Parmar, Ambica, et al. “A Cost-Utility Analysis of Apalutamide for Metastatic Castrationsensitive Prostate Cancer”. Canadian Urological Association Journal, vol. 16, no. 3, Oct. 2021, pp. E126-31, doi:10.5489/cuaj.7495.